Loading...

IPA Virtual Summit 2021

The International Probiotics Association (IPA) and SupplySide Network 365 partner together to provide an experience similar to that of SupplySide West (virtual). Atlantia will present on Wednesday, January 27th.

What does the event offer?

This event will allow attendants to create connections with leading ingredient suppliers & service providers from across the globe. Similarly, product manufacturers and marketers will gain the highest standard of insights and content on the probiotics market. Attendants at the event will have the opportunity to view a series of live (sponsored) presentations and the ability to network seamlessly. 

What is SupplySide Network 365?

It is a digital hub for health and nutrition professionals, to connect, learn and partner with to provide industry solutions. It is always active, not just for singular events. Through this platform you have the ability to connect with people, companies, services and expertise. Furthermore, each event offers unique topics, ensuring you are connecting with relevant professionals.

Medical Director at Atlantia Clinical Trials, Professor Ted Dinan will speak on:

Developing probiotics for Depression and Parkinson's disease.

Speaker bio: Emeritus Professor of Psychiatry and a Principal Investigator in APC Microbiome Ireland at University College Cork. He has been mentioned as part of the Highly Cited Researchers, by Clarivate Analytics 2020 report, and by Expertscape.  Prof. Dinan has promoted the concept of Psychobiotics, probiotics that have a mental health benefit.  He has published over 450 papers and numerous books on the pharmacology and neurobiology of affective disorders. 

 

Do you want to meet our clinical team at Microbiome Movement - Drug Development Europe?

Schedule a meeting with us now!

 

The Microbiome Movement is platform for translational microbiome researchers, uniting the scientific community with the goal to continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development.. Learn more about them: https://microbiome-europe.com

B2B